AVAH (AVAH) Stock Price & Analysis
AVAH (AVAH) fell 0.44% to USD 13.58 as of September 8, 2026 at 08:19 UTC, according to Nexqual real-time market data.
AVAH last closed at USD 13.58; the session ranged USD 13.49–13.83 on volume of 1,844,325 shares. Market capitalization is —, with a 52-week range of USD 5.93–14 (NMS). Source: Nexqual, September 8, 2026 at 08:19 UTC.
Key Statistics (as of September 8, 2026 at 08:19 UTC)
| Price | USD 13.58 |
|---|---|
| Change | ▼ 0.44% (down) |
| Previous Close | USD 13.58 |
| Open | USD 13.58 |
| Day Range | USD 13.49 – 13.83 |
| 52-Week Range | USD 5.93 – 14 |
| Volume | 1,844,325 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (AVAH)
Nexqual's technical model rates AVAH "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 08:19 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 67.9 (neutral) |
| vs SMA50 | Above (USD 10.68) |
| MACD | 0.96 (positive) |
From AVAH's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BVS | Bioventus Inc. | USD 14.07 | ▼ 2.09% |
| ALHC | Alignment Healthcare, Inc. | USD 13.54 | ▼ 0.37% |
| PRVA | Privia Health Group, Inc. | USD 20.66 | ▼ 0.29% |
| LFST | LifeStance Health Group, Inc. | USD 12.73 | ▼ 1.24% |
| DSGN | Design Therapeutics, Inc. | USD 15.14 | ▼ 2.51% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:19 UTC. This page is informational and not investment advice.